Mark as
Challenges and opportunities in using residual newborn screening samples for translational research
"Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."
More by Steve Olson
Recent activity
Rate this book to see your activity here.
Comments and reviews
Please sign in to leave a comment